1. Home
  2. SDHY vs EMBC Comparison

SDHY vs EMBC Comparison

Compare SDHY & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SDHY

PGIM Short Duration High Yield Opportunities Fund

N/A

Current Price

$15.17

Market Cap

377.3M

Sector

Finance

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$6.40

Market Cap

354.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SDHY
EMBC
Founded
2020
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
377.3M
354.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SDHY
EMBC
Price
$15.17
$6.40
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
64.7K
★ 778.1K
Earning Date
01-01-0001
11-24-2026
Dividend Yield
★ 8.46%
0.62%
EPS Growth
N/A
★ 20.90
EPS
★ 1.07
1.03
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.59
P/E Ratio
$14.18
★ $6.27
Revenue Growth
N/A
N/A
52 Week Low
$14.67
$2.77
52 Week High
$16.89
$14.81

Technical Indicators

Market Signals
Indicator
SDHY
EMBC
Relative Strength Index (RSI) 44.01 53.44
Support Level $14.87 $5.64
Resistance Level $16.34 $6.85
Average True Range (ATR) 0.31 0.33
MACD -0.00 -0.03
Stochastic Oscillator 13.87 55.61

Price Performance

Historical Comparison
SDHY
EMBC

About SDHY PGIM Short Duration High Yield Opportunities Fund

PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It mainly invests in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: